CORA15 at checkout→ Expert guidance on wellness, telehealth, and personalized healthcare — backed by science.
This content is for informational purposes only and is not intended as medical advice. Consult a licensed healthcare provider for personalized medical guidance.
What compounded semaglutide/cyanocobalamin or compounded tirzepatide with B12 on a vial means, what the evidence shows and what FDA said in September 2026.
More employers are dropping GLP-1 weight-loss coverage for 2027, and key savings offers end Dec 31, 2026. What is changing, what it costs, and what to do first.
Was your GLP-1 renewal denied because your BMI dropped or your plan changed its criteria? Why it happens, what to ask your prescriber, and how to appeal.
What trials show when people stop or stay on a GLP-1, the maintenance doses on the Wegovy and Zepbound labels, and what 12 months costs by route.
On July 23, 2026, an FDA panel voted to recommend some peptides for compounding — but recommended is not approved, and none is legal to compound today.
Is compounded semaglutide or tirzepatide legal in 2026? The federal framework, what changed after the shortage ended, and how to verify a legitimate provider.
We read the published cancellation, refund, renewal, and membership terms of 18 US GLP-1 telehealth providers and recorded what each one actually says. Cancellation channels range from published self-serve click-paths to email-only channels with notice deadlines — and one provider's terms state email cancellation is not valid. Refund windows range from 72-hour and cooling-off windows to categorical no-refund policies. The full sourced dataset is free to cite.
What actually happens after stopping compounded semaglutide or tirzepatide: what the STEP 1, STEP 4, and SURMOUNT-4 trials show about weight regain, whether there's a withdrawal syndrome, tapering, and how the decision to stop is made with a licensed provider.
How to cancel an Eden (tryeden.com) GLP-1 treatment plan in 2026: fully self-serve in the Eden Member Portal via the Manage tab — pause a shipment, turn off auto-renewal, or select End Treatment. Why prepaid 3, 6, and 12-month plans keep shipping until the paid term completes, when you can still cancel an order without being billed, and how the medical-exception partial refund works.
How to cancel a Henry Meds subscription in 2026: self-serve on the account page of the Henry Meds patient portal, by emailing ask@henrymeds.com, or by calling (909) 787-2342. When to cancel relative to your billing date, what happens to a refill already in motion, and how to confirm the cancellation stuck.
How to cancel a Mochi Health membership in 2026: select "cancel subscription" in your Mochi account or call (619) 648-1247 — per Mochi's own terms, email is NOT a valid cancellation channel. Why cancellation takes effect at the end of your current term with no mid-term refund, how the separate medication subscription works, and the refill deadline that decides whether one more shipment bills.
How to cancel a Jenny Craig auto-ship plan in 2026: call 1-800-727-8046 or email customersupport@jennycraig.com before the 6:00 p.m. ET cutoff the day before your order is fulfilled. Why deleting your account does not stop auto-ship, why prepaid food orders are non-refundable even unshipped, and the separate Club Jenny subscription that keeps billing until cancelled on its own.
Cora Health and Noom take structurally different approaches to weight loss in 2026. Noom is a psychology-based behavior-change program ($17.42–$42.25/month) with medical tiers layered on top: its compounded GLP-1Rx program runs $129 for the first month, then $279/month. Cora is a medication-first compounded GLP-1 telehealth program at $99–$225/month all-inclusive with flat published pricing. Compounded medications are not FDA-approved and are not therapeutically equivalent to branded products. Individual results vary.
How to cancel a Noom subscription or trial in 2026: in the app (profile → Settings → Manage Subscription), on the web via the Subscription Portal at account.noom.com, or through Apple/Google if you subscribed in the app store. What to know about Noom's auto-renewal, the 14-day refund window, why Noom Med refunds end the moment a prescription is written, and how to confirm your cancellation went through.
How to cancel a Nutrisystem auto-delivery plan in 2026: call 1-800-585-5483 (option 1, then option 4) or use live chat before 6:00 p.m. ET the day before your next order is fulfilled. What the $125 auto-delivery discount chargeback is, when the 7-day money-back guarantee is the better move, and how to confirm your cancellation actually went through.
How to cancel an OPTAVIA Premier+ membership in 2026: self-serve on OPTAVIA.com (Account → My OPTAVIA Premier+ → Cancel Premier+ Membership) or in the OPTAVIA App (Account → Manage Premier+), before 6:00 p.m. ET the day before your order processing date. Why cancelling the membership does not cancel a pending order, and how to confirm both.
How to cancel the Ro Body Program (Ro's weight-loss membership) in 2026: cancel yourself online at my.ro.co, or email Ro support. Step-by-step instructions, plus what to know about the $149/month membership fee, billing timing, refunds, and confirming your cancellation went through.
How to cancel a Calibrate membership in 2026: email Calibrate's team with at least 7 days' notice before your next billing cycle. Step-by-step instructions, plus what to know about the Initial Term commitment, the 72-hour refund window, the Results Money Back Promise, and confirming your cancellation.
How to cancel a Found (joinfound.com) weight-loss membership in 2026: email Found support, since there is no self-serve in-app cancel button. Step-by-step instructions, plus what to know about auto-renewal, the ~36-hour effective window, refunds, and confirming your cancellation.
Cancel a WeightWatchers (WW) membership in 4 steps: sign in at weightwatchers.com/us/cancellation, or cancel in Apple or Google Play if billed there. Checked Sept 2026.
Compounded semaglutide typically lasts 28 days refrigerated once opened, and up to the labeled beyond-use date (often 60-90 days) unopened. Storage temperature, light exposure, and pharmacy formulation all matter. Practical guide with what to do at room temperature, during travel, and on accidental warming.
GLP-1 microdosing refers to using doses below the FDA-approved therapeutic range, typically for tolerability, cost, or maintenance. Side-by-side chart of semaglutide and tirzepatide microdose ranges, where each dose falls relative to FDA-approved schedules, and what the published evidence actually says.
Full compounded semaglutide weight-loss dosage chart following the STEP 1 trial titration: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg weekly over ~16 weeks. Side effects to expect at each step, what to do if you cannot titrate up, and how compounded versions differ from FDA-approved Wegovy®.
Eight clinical reasons compounded tirzepatide patients stop losing weight — starter dose, plateau timing, protein deficit, sleep, medications, and what providers actually do next.
12 US compounded GLP-1 telehealth providers compared on price ($99–$348/mo), pharmacy transparency, and LegitScript status. May 2026 data. Compounded medications are not FDA-approved.
Comprehensive medical guide covering common side effects, serious warnings, and contraindications for semaglutide and tirzepatide. Evidence-based information from STEP 1 (Wilding et al., NEJM 2021) and SURMOUNT-1 (Jastreboff et al., NEJM 2022), plus FDA-approved prescribing information for Wegovy, Ozempic, Zepbound, and Mounjaro.
Compounded semaglutide and tirzepatide prepared by US-licensed 503A pharmacies under valid patient-specific prescriptions can be reasonably safe when sourced from reputable pharmacies that follow USP 795/797 standards, conduct third-party testing, and operate under state pharmacy board oversight. Compounded medications are not FDA-approved and are not therapeutically equivalent to brand-name products (Ozempic, Wegovy, Mounjaro, Zepbound). Per FDA: compounded drugs are not reviewed by FDA for safety, effectiveness, or quality before they are marketed.
Transparent guide to Cora's pricing structure, what's included in each subscription, shipping policies, and billing details. Everything you need to know about costs before starting.
Complete guide to using Cora's patient portal for medication refills, dose adjustments, telehealth follow-ups, and 24/7 messaging support. Manage your entire wellness journey online.
Step-by-step walkthrough of Cora's signup process and online medical assessment. Learn what to expect, what questions you'll answer, and how quickly you can start treatment.
Evidence-based strategies for women over 40 using tirzepatide through menopause. Practical guidance on hormonal changes, weight loss, and wellness during life transitions.
Semaglutide-driven weight loss measurably improves obstructive sleep apnea (OSA) by reducing parapharyngeal fat that obstructs the upper airway during sleep. The SURMOUNT-OSA trial (NEJM 2024) showed a 55–63% reduction in apnea-hypopnea index (AHI) with FDA-approved tirzepatide. Brand-name Wegovy is FDA-approved for chronic weight management. Rybelsus is FDA-approved oral semaglutide for type 2 diabetes (not currently FDA-approved for OSA). Compounded semaglutide is not FDA-approved. Individual results vary.
Plant-based meal planning for tirzepatide users. Protein-rich vegan recipes, nutrient optimization strategies, and tips for healthy eating on GLP-1 medications.
Essential guide to semaglutide use and fertility for women over 35. Safety considerations, timing around conception, and optimizing reproductive health on GLP-1 therapy.
Complete guide to traveling with tirzepatide. Storage tips, TSA guidelines, international travel, and maintaining your weekly injection routine away from home.
The most common tirzepatide side effects are gastrointestinal: nausea (~30–45%), diarrhea (~17–22%), constipation (~10–18%), and vomiting (~6–13%). Most are mild-to-moderate and concentrated in the first 4–12 weeks during dose escalation. Severe or persistent symptoms warrant provider review. Black box warning: thyroid C-cell tumors observed in rodent studies; contraindicated in patients with personal or family history of medullary thyroid carcinoma or MEN 2. SURMOUNT-1 trial data (NEJM 2022) reflects FDA-approved tirzepatide. Compounded tirzepatide is not FDA-approved. Individual results vary.
Month-by-month semaglutide before-and-after timeline based on STEP 1 trial data for FDA-approved semaglutide (Wegovy®). Individual results vary.
Comprehensive guide to compounded semaglutide for weight loss. What it is, how it differs from Ozempic, clinical trial evidence, safety standards, cost comparison, and how to get it online through a licensed provider.
Complete guide to GLP-1 receptor agonist medications for weight loss. How semaglutide and tirzepatide work, clinical trial evidence, side effects, cost comparison, and how to access treatment through a licensed provider.
10 online GLP-1 providers compared for 2026: cash-pay prices from $99 to $348/month, which name their pharmacy, and which are LegitScript-certified. Compounded meds aren't FDA-approved.
Only a small number of US telehealth providers offer compounded GLP-1 medications at $100/month or less with dose-stable, all-inclusive pricing. The most verifiable sub-$100 options as of May 2026 are Cora Health (Essential Annual Plan $99/month), Trimi Health ($99/month), and Sesame Care (per-visit model from $99/month). Compounded medications are not FDA-approved and are not therapeutically equivalent to brand-name products like Ozempic, Wegovy, Mounjaro, or Zepbound.
The leading compounded tirzepatide telehealth providers as of July 2026 by verified all-in monthly cost split by commitment length. On annual upfront billing: Trimi Health ($125/month) and Cora Health Premium Annual ($135/month) are the lowest. On monthly billing (no annual commitment): Cora Health Premium Monthly ($225/month) is the cheapest, followed by Trimi Health Monthly ($235/month) and Eden ($298/month, following a 2026 required-membership addition). Compounded tirzepatide is not FDA-approved and is not therapeutically equivalent to Mounjaro or Zepbound. SURMOUNT-1 trial efficacy data (NEJM 2022) reflects FDA-approved products only.
The leading compounded semaglutide telehealth providers as of May 2026 by verified all-in monthly cost include Trimi Health ($99/month), Cora Health Essential Annual ($99/month), Belle Health ($119/month — note February 2026 FDA Warning Letter), Pomegranate Health ($119/month plus $75 consultation fee), Eden ($129/month first), Ivim Health ($149.99/month effective with $74.99 membership), and Henry Meds ($179/month starter with dose-tier escalation). Compounded semaglutide is not FDA-approved or therapeutically equivalent to Ozempic or Wegovy.
A 2026 cost comparison of GLP-1 medications across the three primary supply channels: compounded telehealth providers ($99-$479/month), manufacturer direct-pay programs (NovoCare for Wegovy at $149-$399/month and LillyDirect for Zepbound at $299-$699/month), and retail brand-name pricing ($1,086-$1,349/month). Based on Cora Health's public CC-BY-4.0 pricing dataset of 49 verified pricing rows. Compounded medications are not FDA-approved.
Top compounded semaglutide telehealth providers serving California residents in 2026, ranked by all-in monthly cost. California residents have access to all major US compounded GLP-1 telehealth platforms including Cora Health ($99/month annual plan), Trimi Health ($99/month), Eden, Henry Meds, Mochi, Lemonaid, MEDVi, and Hims. California state law adds specific compounding regulations layered on top of federal 503A rules. Compounded medications are not FDA-approved.
Top compounded tirzepatide telehealth providers serving Texas residents in 2026, ranked by all-in monthly cost. Texas residents have access to all major US compounded GLP-1 telehealth platforms. Texas is the home state of Empower Pharmacy, one of the largest 503A/503B compounding pharmacies in the country. VialsRx — one of Cora Health's two 503A pharmacy partners — is licensed by the Texas State Board of Pharmacy. Compounded medications are not FDA-approved.
Step-by-step guide to canceling the Hims Weight Loss Membership ($39 the first month, then $149/month on top of medication) and switching to a compounded GLP-1 program. Hims no longer advertises or lists compounded GLP-1s. Cora Health’s Essential Plan (compounded semaglutide) is $175 billed monthly, or $99/month on the 12-month plan ($1,188 billed upfront, prepaid); plans renew automatically. Compounded medications are not FDA-approved.
A day-by-day guide to the first 7 days of compounded semaglutide treatment. Most patients start at the 0.25mg weekly starter dose. Initial side effects (nausea, fatigue, mild constipation) are most common in days 2-4 after the first injection. Food noise reduction is typically reported within 3-7 days. The STEP 1 trial demonstrated 14.9% mean weight loss over 68 weeks at the FDA-approved 2.4mg maintenance dose. Compounded semaglutide is not FDA-approved.
Nausea is the most common side effect of semaglutide, reported by approximately 44% of patients in the STEP 1 clinical trial. Most nausea is mild-to-moderate and improves over 4-8 weeks as the body adjusts. Evidence-based management includes smaller more frequent meals, ginger, hydration, slow titration, and timing of doses. Severe or persistent nausea may warrant dose reduction or provider consultation. Compounded medications are not FDA-approved.
Alcohol is not strictly contraindicated with compounded or brand-name semaglutide, but the combination can worsen nausea, gastrointestinal side effects, and dehydration. Many patients report reduced desire for alcohol while on GLP-1 medications. Patients should generally limit or avoid alcohol during the first 8-12 weeks of treatment and during dose escalation. Compounded semaglutide is not FDA-approved. This article provides general information, not medical advice — consult your prescribing provider.
Under-eating is one of the most common but under-discussed challenges on compounded GLP-1 medications. Patients with appetite suppression from semaglutide or tirzepatide can drop below the minimum caloric and protein intake needed to preserve muscle mass and metabolic health. Most patients should aim for at least 1,200-1,500 calories and 60-80 grams of protein daily, even when appetite is suppressed. Compounded medications are not FDA-approved.
Compounded tirzepatide costs approximately $135–$479/month versus $1,086/month for brand-name Zepbound retail or $299–$699/month via LillyDirect direct-pay vials. Compounded versions are not FDA-approved and are not therapeutically equivalent to Mounjaro or Zepbound. Clinical trial data (SURMOUNT-1: 22.5% mean weight loss over 72 weeks, NEJM 2022) reflects the FDA-approved branded product only. Individual results vary.
Compounded GLP-1 medications (compounded semaglutide, compounded tirzepatide) cost $99–$225/month versus $1,000–$1,100+/month for FDA-approved brand-name GLP-1s (Ozempic®, Wegovy®, Mounjaro®, Zepbound®). Compounded versions are not FDA-approved or therapeutically equivalent. Clinical trial data (STEP 1: 14.9% weight loss, SURMOUNT-1: 22.5%, both published in NEJM) reflects FDA-approved products only. Individual results vary.
Hims: $149/mo membership ($39 first month) + brand-name meds from $149/mo. Cora: compounded semaglutide, not FDA-approved, $175 billed monthly, auto-renews.
Cora: compounded semaglutide $175 billed monthly, auto-renews; not FDA-approved or equivalent to Wegovy®. Ro: membership + FDA-approved meds, $298–$598/mo.
Cora Health and Henry Meds both offer compounded GLP-1 weight loss telehealth in 2026. Cora’s monthly cost stays flat across all doses ($99–$175/month); Henry Meds advertises $179/month as its starting price for both compounded semaglutide and tirzepatide and does not publicly list maintenance-dose pricing. Other differences: pharmacy disclosure depth and LegitScript certification. Compounded medications are not FDA-approved.
As of July 2026, Eden (TryEden) charges $99/mo medication + a newly required $99/mo membership = $198/mo total for compounded semaglutide. Compare a $99/mo all-inclusive alternative — ~50% cheaper, with both pharmacies named publicly. Compounded meds aren't FDA-approved.
Cora Health and Mochi Health both offer compounded GLP-1 weight loss telehealth in 2026. Mochi uses synchronous video consultations with board-certified obesity medicine specialists; Cora uses an async telehealth model at lower cost. Key differences: clinical depth (live video vs async), total monthly cost, pharmacy transparency, and which patient profile each fits. Compounded medications are not FDA-approved.
Cora Health and PlushCare both offer GLP-1 weight loss telehealth in 2026 but follow fundamentally different models. Cora provides compounded semaglutide and tirzepatide on all-inclusive monthly plans starting at $99/month with no membership, no separate consultation fee, and a publicly named compounding pharmacy. PlushCare prescribes only FDA-approved brand-name GLP-1s (Wegovy, Ozempic, Zepbound, Mounjaro), uses a $19.99/month membership plus separate per-visit charges, and is designed primarily for patients using insurance. Compounded medications are not FDA-approved or therapeutically equivalent to FDA-approved products.
Calibrate costs $199/mo (~$2,388/yr) — and GLP-1 medication is billed separately through insurance. Compare a $99/mo all-inclusive compounded alternative. Compounded meds aren't FDA-approved.
Cora Health and WeightWatchers Clinic (formerly Sequence) both offer GLP-1 weight loss telehealth in 2026 with structurally different models. Cora provides compounded semaglutide ($99/month annual) and compounded tirzepatide ($135/month annual) on all-inclusive cash-pay subscriptions with no separate membership. WeightWatchers Clinic prescribes FDA-approved brand-name GLP-1s (Wegovy, Zepbound) through a 12-month commitment combining clinic membership with the WW behavioral program; effective monthly cost ranges $374–$473 for cash-pay patients. Compounded medications are not FDA-approved and are not therapeutically equivalent to Wegovy or Zepbound. Individual results vary.
Cora Health and Lemonaid Health both offer compounded GLP-1 weight loss telehealth in 2026, making this one of the few direct compounded-vs-compounded comparisons in the market. Cora Health offers all-inclusive plans at $99–$225/month with no membership and publicly names Hallandale Pharmacy and VialsRx (both US-licensed 503A pharmacies) as its compounding partners. Lemonaid charges a $49/month membership plus $229–$299/month medication for a $278–$348/month effective monthly cost. Compounded medications are not FDA-approved or therapeutically equivalent to FDA-approved products.
Cora Health and MEDVi both offer compounded GLP-1 telehealth in all 50 US states with LegitScript certification. The most consequential difference is monthly cost: Cora's annual Essential Plan starts at $99/month all-inclusive vs MEDVi's $299/month ongoing for compounded semaglutide ($179 introductory first month). For compounded tirzepatide, Cora's annual Premium Plan is $135/month vs MEDVi's $349/month. Cora publicly names Hallandale Pharmacy and VialsRx as its compounding pharmacy partners; MEDVi promotes its 503B partnerships but does not name a specific pharmacy publicly. Compounded medications are not FDA-approved.
Cora Health and Found both offer GLP-1 weight loss telehealth in all 50 US states but use different program models. Cora's annual Essential Plan is $99/month all-inclusive for compounded semaglutide. Found uses a tiered membership structure starting at $99/month for membership-only with medication billed separately, and ranges to $349-$499/month all-in depending on tier and medication type. Found bundles video consultations with board-certified obesity medicine specialists and behavioral coaching; Cora is a focused medication-and-monitoring program without bundled coaching. Compounded medications are not FDA-approved.
Cora Health and Sesame Care both advertise $99/month entry pricing for GLP-1 telehealth, but the underlying models differ. Cora is a focused all-inclusive compounded GLP-1 subscription ($99-$225/month). Sesame is a broader telehealth marketplace offering pay-per-visit GLP-1 consultations with separate medication fulfillment, plus monthly subscription paths. Cora publicly names Hallandale Pharmacy and VialsRx as its compounding pharmacy partners; Sesame works with multiple pharmacy partners depending on the medication and patient location. Compounded medications are not FDA-approved.
Belle Health: compounded semaglutide $109/mo, compounded tirzepatide $189/mo (12-mo supply, Sept 2026) vs $99/$135/mo annual plans that auto-renew. Not FDA-approved.
Cora Health and Ivim Health both offer compounded GLP-1 telehealth across nearly all US states with LegitScript-related certifications. Cora's annual Essential Plan is $99/month all-inclusive for compounded semaglutide. Ivim charges $75/month medication plus $74.99/month membership = approximately $150/month effective for compounded semaglutide. Cora publicly names Hallandale Pharmacy and VialsRx as its compounding pharmacies; Ivim has 470,000+ patients served and 36,000+ Trustpilot reviews. Compounded medications are not FDA-approved.
Cora Health and Pomegranate Health both offer compounded GLP-1 telehealth with no monthly membership fee. As of September 2026, Cora's Essential Plan is $99/month all-inclusive for compounded semaglutide on a 12-month plan ($1,188 billed every 12 months, renews automatically) vs Pomegranate's "starts at $119/month"; compounded tirzepatide is $135/month at Cora on the annual plan vs "starts at $159/month" at Pomegranate. Cora publicly names Hallandale Pharmacy and VialsRx as its pharmacy partners; Pomegranate's product pages do not name theirs. Both are LegitScript-certified. Compounded medications are not FDA-approved.
Compounded tirzepatide on monthly billing, compared as of May 12, 2026: Cora Health Premium Monthly at $225/month all-inclusive (billed monthly, renews until cancelled), Eden at $229/month, and Trimi Health Monthly at $235/month. Mochi Health and Lemonaid Health 6-month plans land at $278/month effective with their required membership fees. Compounded tirzepatide is not FDA-approved and is not therapeutically equivalent to Mounjaro® or Zepbound®. Individual results vary.
Cora Health and Trimi Health are direct competitors offering compounded semaglutide and compounded tirzepatide via telehealth at similar all-inclusive price points. The full tier ladder split: on annual commitment Trimi is cheaper ($125/month vs Cora $135/month for compounded tirzepatide); on monthly commitment Cora is cheaper ($225/month vs Trimi $235/month, effective May 12, 2026); on quarterly and 6-month tiers they are exact ties ($199/month and $175/month). Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved products like Ozempic, Wegovy, Mounjaro, or Zepbound. Individual results vary.
How compounded tirzepatide works: dual GIP/GLP-1 mechanism, SURMOUNT-1 weight loss data, dosing, and how Cora's licensed providers prescribe, with fulfillment via Hallandale Pharmacy or VialsRx.
Semaglutide vs tirzepatide head-to-head: SURMOUNT-5 reported ~20.2% vs ~13.7% mean weight loss. Mechanism, side effects, dosing, and compounded cost compared.
Get personalized care guided by licensed providers.
See If You Qualify